Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Association of Adiponectin Gene Polymorphism rs266729 in Obese People with Type Two Diabetes Mellitus in North Bulgaria's Population

Rashev T., Trifonov S.

Laboratory Study with a reported sample of 156 on Type 2 Diabetes, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Int J Mol Sci (2026)
Reported sample size
156
Source database
Europe PMC
PMID
41828577
PMCID
PMC12985942
DOI
10.3390/ijms27052359

Abstract (original English)

The alarming surge in obesity rates represents a critical health concern in developed nations. This condition is associated with several health issues grouped under the term metabolic syndrome. This alarming data mandates an investigation into the causes and risk of this syndrome. One category of causes is genetic factors. The adiponectin gene has been subject to several studies exploring its single nucleotide polymorphisms, especially rs266729, across diverse populations. This study included 156 subjects. Body weight, body mass index, and blood pressure were measured, and levels of fasting plasma glucose (FPG), total cholesterol, triglycerides, HDL, and LDL were determined. Genotyping was performed. There was significant association of rs266729 polymorphism with obesity and type 2 diabetes mellitus (T2DM), with notably higher frequency of the G allele among these subjects. Additionally, the results demonstrated significant influence on the detected levels of HDL. Individuals carrying the homozygous (GG) and heterozygous (CG) genotypes exhibited a three-fold and two-fold increased risk of elevated FPG levels, respectively. There was also a significant association of these genotypes with T2DM when compared with the wild-type genotype (CC). These observations strongly indicated a potential involvement of the adiponectin gene polymorphism rs266729 in the pathogenesis of T2DM among

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansDiabetes Mellitus, Type 2ObesityGenetic Predisposition to DiseaseBlood GlucoseBody Mass IndexGene FrequencyGenotypePolymorphism, Single NucleotideAlleles

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research